Stereotaxis, Inc.
NYSE · Healthcare · Electromedical & Electrotherapeutic Apparatus · St.Louis, MO
STXS chart
What traders are saying about $STXS
Latest postsStereotaxis, Inc. news
- Stereotaxis, Inc. News — DUS:RJR1
TradingView ·
- Stereotaxis Stock Price Forecast. Should You Buy STXS?
StockInvest.us ·
- Canon, Stereotaxis Collaborate on Robotic Electrophysiology Technology
www.dicardiology.com ·
- First-in-Human Coronary Intervention Study Results of Next-Gen Robotic System Presented at TCT
Diagnostic and Interventional Cardiology ·
- Is Stereotaxis (NYSEAMERICAN:STXS) Jumping 11.86% Pre-Market as Five Names Rise Before Earnings?
Kalkine ·
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga ·
- First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT
Yahoo Finance ·
- Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology
Yahoo Finance ·
- Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Yahoo Finance ·
- Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
Yahoo Finance ·
- Global Electrophysiology Devices Market Size, Share, Growth, and Forecast 2026-2035 | Pulsed Field Ablation and 3D Mapping Fuel 12.40% CAGR to USD 30.16 Billion by 2035
Yahoo Finance ·
- ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters
Yahoo Finance ·
Stereotaxis, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $32.4M | $26.9M | $26.8M | $28.1M |
| Net income | -$21.6M | -$24.0M | -$20.7M | -$18.3M |
| Diluted EPS | $-0.25 | $-0.30 | $-0.27 | $-0.26 |
| Total assets (year end) | $52.3M | $46.7M | $41.9M | $53.4M |
| Cash and equivalents (year end) | $13.4M | $12.2M | $19.8M | $8.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Stereotaxis, Inc.
- Ticker
- STXS (NYSE)
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- St.Louis, MO
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1289340
Frequently asked questions
What exchange is Stereotaxis, Inc. listed on?
Stereotaxis, Inc. trades on the NYSE under the ticker symbol STXS.
What industry is Stereotaxis, Inc. in?
Stereotaxis, Inc. is classified by the SEC under "Electromedical & Electrotherapeutic Apparatus", part of the Healthcare sector on StockTweeting.
Where is Stereotaxis, Inc. headquartered?
Stereotaxis, Inc.'s business address on file with the SEC is in St.Louis, MO.
When does Stereotaxis, Inc.'s fiscal year end?
Stereotaxis, Inc.'s fiscal year ends on December 31.
How much revenue did Stereotaxis, Inc. report?
Stereotaxis, Inc. reported $32.4M in revenue for calendar year 2025, according to its SEC filings.